Consortium of Lung Repair and Regeneration: Building the Foundation (U01)

The summary for the Consortium of Lung Repair and Regeneration: Building the Foundation (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Consortium of Lung Repair and Regeneration: Building the Foundation (U01): The National Heart, Lung, and Blood Institute (NHLBI) invites applicants to participate in the Lung Repair and Regeneration Consortium (LRRC). The goal of the Consortium is to bring together multidisciplinary teams of investigators, cutting edge technologies, innovative strategies, and new ideas to catalyze research on lung regeneration and repair. The Consortium will contain collaborative research support and skills development components to be administered after the Consortium is assembled. The purpose of this FOA is to attract new expertise into multidisciplinary teams to investigate novel hypotheses relevant to lung repair/regeneration and to develop a highly interactive and synergistic Consortium of investigators who will share ideas, data, and resources to move the field of lung regeneration forward toward development of new therapies for human diseases. This FOA solicits Research Project Cooperative Agreement (U01) applications from institutions/organizations that propose (1) to apply novel technologies to test innovative hypotheses of mechanisms that control adaptive and maladaptive lung repair/regeneration after injury and include studies to validate these mechanisms are relevant in humans; and (2) to develop two or more novel tools (e.g., reagents, models, imaging, and/or data analysis tools) that would accelerate research progress in lung regeneration. Applicants are strongly encouraged to use the multiple Principal Investigator mechanism to organize multidisciplinary teams that must include new collaborations and expertise in two or more of the following disciplines: developmental biology, stem cell biology, pulmonary medicine, lung injury, physiology, genomics, tissue or bioengineering, nanotechnology, and integrative, systems approaches.

Federal Grant Title:	Consortium of Lung Repair and Regeneration: Building the Foundation (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HL-12-006
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.838
CFDA Descriptions:	Lung Diseases Research
Current Application Deadline:	Feb 10, 2011
Original Application Deadline:	Feb 10, 2011
Posted Date:	Oct 27, 2010
Creation Date:	Oct 27, 2010
Archive Date:	Mar 13, 2011
Total Program Funding:	$4,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:	6
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Limited Competition: Physician Scientist Transition to Independence in Blood Science Resea...; • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...; • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...; • Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clin...; • Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models; • Lung Response to Inhaled Highly Toxic Chemicals; • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
More Grants from the National Institutes of Health: • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...; • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional); • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...; • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...